NC4 News

Immix Command Center software platform allows Sanofi to manage their cascading security environment Customer Boston-based biotechnology company, Genzyme is an organisation dedicated to the research of rare genetic-related diseases. Acquired by French global healthcare giant Sanofi in 2011, Genzyme has made the security of its physical and intellectual assets a priority since the 1990s, and was among the first companies to define security as a process that encompasses enterpri...